Callan JMB Faces Nasdaq Delisting After Failing Equity Requirement; Appeals to Hearings Panel
CJMB has more than doubled off its 52-week low of $0.65.
Summary
Nasdaq determined Callan JMB failed to meet the $2.5M stockholders' equity requirement by the October 5 deadline, triggering a trading suspension set for October 21. The company requested a hearing on October 14, which stays the suspension pending the Panel's decision.
Key Events · Legal and Risk Events · CJMB
-
Nasdaq Staff Determination of Non-Compliance
On October 12, 2026, Nasdaq notified Callan JMB that it failed to meet the terms of the extension to regain compliance with the $2.5 million stockholders' equity requirement by the October 5, 2026 deadline.
-
Trading Suspension and Delisting Scheduled
Unless an appeal was requested by October 19, 2026, trading of CJMB common stock would be suspended at the opening of business on October 21, 2026, and a Form 25-NSE would be filed to remove the securities from Nasdaq listing and registration.
-
Hearing Request Stays Suspension
On October 14, 2026, the company requested a hearing before a Nasdaq Hearings Panel under Listing Rule 5815(a), which stays the suspension and the Form 25-NSE filing pending the Panel's decision.
-
Capital Raising Shortfall Cited
Nasdaq cited the company's inability to complete its capital raising initiatives as the reason it could not demonstrate compliance with the equity requirement.
Analysis · CJMB · Trade & Services
Nasdaq has determined Callan JMB failed to regain compliance with the $2.5 million stockholders' equity requirement by the October 5, 2026 extension deadline, and trading will be suspended at the open on October 21 unless the company wins its appeal. The company filed for a hearing on October 14, which temporarily stays the suspension and the Form 25-NSE delisting filing, but there is no assurance the Panel will grant continued listing. This is a critical survival event for a company already carrying a going concern warning and a 17% revenue decline — a delisting would push CJMB to the OTC market, sharply reducing liquidity and institutional ownership. The company's stated path to compliance is completing capital raising initiatives, which have so far been insufficient.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 45.2% of the 299 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.26%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CJMB was trading at $2.20 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $12.7M. The 52-week trading range was $0.65 to $5.61. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.